Shining a light on male infertility: the power of near-infrared photobiomodulation therapy for human asthenozoospermia

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Sperm motility is a crucial factor in male fertility. Photobiomodulation (PBM) has been reported to increase sperm motility but lacks a standardized protocol. We collected asthenozoospermic (n=70) and normozoospermic (n=20) semen. The asthenozoospermic samples were irradiated with an 810 nm diode laser at 0.25W, 0.5W, 1W, and 2W. Sperm motility was assessed immediately, after 30 and 60 minutes. A sample size calculator, unpaired t-test and one-way ANOVA with post-hoc Tukey HSD tests were used for statistics. One and 2 W were the most effective outputs in increasing progressive motility compared to control (p<0.001). The maximum effect was immediately after 1 W-PBM (p<0.001), and decreased after 60 minutes (p<0.001). Time physiologically decreased vitality (p<0.001), but less in the 1W-PBM samples (p<0.05). 1W-PBM did not affect chromatin condensation. Asthenozoospermic samples displayed an impairment of 80% in oxygen consumption and ATP production and a slight inefficiency of oxidative phosphorylation compared to normozoospermic samples (p<0.001). 1W-PBM partially restored the functionality of aerobic metabolism (p<0.001) by recovery of oxidative phosphorylation efficiency. PBM did not affect lactate dehydrogenase (glycolysis pathway). No irradiated samples increased accumulated malondialdehyde, a marker of lipidic peroxidation. In conclusion, PBM improves progressive motility in asthenozoospermia through increased mitochondrial energetic metabolism without harmful oxidative stress.

Article activity feed